TWI379686B - - Google Patents
Download PDFInfo
- Publication number
- TWI379686B TWI379686B TW95131393A TW95131393A TWI379686B TW I379686 B TWI379686 B TW I379686B TW 95131393 A TW95131393 A TW 95131393A TW 95131393 A TW95131393 A TW 95131393A TW I379686 B TWI379686 B TW I379686B
- Authority
- TW
- Taiwan
- Prior art keywords
- coating
- ethanol
- chinese medicine
- extract
- medicine composition
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 155
- 239000011248 coating agent Substances 0.000 claims description 90
- 238000000576 coating method Methods 0.000 claims description 90
- 239000003814 drug Substances 0.000 claims description 89
- 239000006187 pill Substances 0.000 claims description 66
- 239000000203 mixture Substances 0.000 claims description 63
- 238000002360 preparation method Methods 0.000 claims description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 55
- 239000000463 material Substances 0.000 claims description 47
- 239000000843 powder Substances 0.000 claims description 43
- 238000010992 reflux Methods 0.000 claims description 43
- 239000007788 liquid Substances 0.000 claims description 42
- 241000125175 Angelica Species 0.000 claims description 37
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 37
- 239000008188 pellet Substances 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 29
- 206010019233 Headaches Diseases 0.000 claims description 28
- 231100000869 headache Toxicity 0.000 claims description 27
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 22
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 22
- 241000913745 Spatholobus Species 0.000 claims description 17
- 238000000605 extraction Methods 0.000 claims description 17
- 235000008216 herbs Nutrition 0.000 claims description 17
- 239000012141 concentrate Substances 0.000 claims description 16
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 15
- 244000179560 Prunella vulgaris Species 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 15
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 15
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 15
- 241000249820 Lipotes vexillifer Species 0.000 claims description 14
- 241000405414 Rehmannia Species 0.000 claims description 12
- 239000000796 flavoring agent Substances 0.000 claims description 10
- 235000019634 flavors Nutrition 0.000 claims description 10
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 10
- 230000004584 weight gain Effects 0.000 claims description 10
- 235000019786 weight gain Nutrition 0.000 claims description 10
- 235000010674 Prunella vulgaris Nutrition 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 8
- 244000236658 Paeonia lactiflora Species 0.000 claims description 7
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 7
- 238000001694 spray drying Methods 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 238000000889 atomisation Methods 0.000 claims description 6
- 239000011230 binding agent Substances 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 239000007888 film coating Substances 0.000 claims description 6
- 238000009501 film coating Methods 0.000 claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 4
- 241000411851 herbal medicine Species 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 235000003642 hunger Nutrition 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims 6
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims 1
- 229940032147 starch Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 description 46
- 239000008187 granular material Substances 0.000 description 31
- 230000002829 reductive effect Effects 0.000 description 27
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 23
- 210000004556 brain Anatomy 0.000 description 21
- 241000699670 Mus sp. Species 0.000 description 17
- 241000157352 Uncaria Species 0.000 description 17
- 210000002966 serum Anatomy 0.000 description 16
- 230000000694 effects Effects 0.000 description 13
- 239000000706 filtrate Substances 0.000 description 12
- 241000405911 Rehmannia glutinosa Species 0.000 description 11
- 238000004090 dissolution Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- 239000007921 spray Substances 0.000 description 10
- 208000000114 Pain Threshold Diseases 0.000 description 9
- 230000037040 pain threshold Effects 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 241000758794 Asarum Species 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 229960000583 acetic acid Drugs 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 241000382455 Angelica sinensis Species 0.000 description 7
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 7
- 229960001138 acetylsalicylic acid Drugs 0.000 description 7
- 239000002662 enteric coated tablet Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000005054 agglomeration Methods 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000002020 sage Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 239000010959 steel Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 241000800405 Spatholobus suberectus Species 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 238000007922 dissolution test Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000002893 slag Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016059 Facial pain Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 108090000951 RNA polymerase sigma 70 Proteins 0.000 description 1
- 208000010476 Respiratory Paralysis Diseases 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000214513 Uncaria sinensis Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 238000011978 dissolution method Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000002981 neuropathic effect Effects 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- HUAUNKAZQWMVFY-UHFFFAOYSA-M sodium;oxocalcium;hydroxide Chemical compound [OH-].[Na+].[Ca]=O HUAUNKAZQWMVFY-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000004018 waxing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW95131393A TW200810771A (en) | 2006-08-25 | 2006-08-25 | Traditional Chinese medicine composition for treating headache and medicament and preparing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW95131393A TW200810771A (en) | 2006-08-25 | 2006-08-25 | Traditional Chinese medicine composition for treating headache and medicament and preparing method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200810771A TW200810771A (en) | 2008-03-01 |
| TWI379686B true TWI379686B (enExample) | 2012-12-21 |
Family
ID=44767474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW95131393A TW200810771A (en) | 2006-08-25 | 2006-08-25 | Traditional Chinese medicine composition for treating headache and medicament and preparing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TW200810771A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526214B (zh) * | 2012-02-01 | 2013-09-04 | 武汉药谷科技开发有限公司 | 一种治疗血管神经性头痛、偏头痛的中药制剂 |
-
2006
- 2006-08-25 TW TW95131393A patent/TW200810771A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200810771A (en) | 2008-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2016173509A1 (en) | Compositions comprising cyclocarya paliurus extract and preparation method and uses thereof | |
| CN110327451A (zh) | 治疗风寒感冒的中药组合物及其制备方法 | |
| CN106390048A (zh) | 小柴胡汤及柴胡加龙骨牡蛎汤的萃取方法 | |
| JP5162457B2 (ja) | 頭痛を治療するための漢方薬組成物、製剤及びそれを製造する方法。 | |
| CN103006831B (zh) | 一种升血小板胶囊中药组合物及其制备方法 | |
| TWI379686B (enExample) | ||
| TW201347768A (zh) | 促進毛髮生長之中草藥組成物及其製備方法 | |
| CN101890152A (zh) | 山药糖蛋白在制备抗缺氧、抗疲劳类的药物的用途 | |
| CN104288514A (zh) | 一种用于治疗甲状腺功能亢进的中药 | |
| CN103494916B (zh) | 一种具有降低血糖功效的中药组合物及其制备方法和应用 | |
| RU2430734C1 (ru) | Гранулы с растительным экстрактом для профилактики и комплексного лечения язвенной болезни желудка | |
| CN109589343A (zh) | 一种解热抗炎的中药有效部位组合物 | |
| CN1278731C (zh) | 复方柴胡药物制剂 | |
| CN101543523B (zh) | 维吾尔药菊苣复方提取工艺 | |
| CN112089783A (zh) | 中药组合物在制备预防或/和治疗肥胖的药物中的应用 | |
| CN103751621B (zh) | 一种治疗崩漏的药物制剂 | |
| CN103432386A (zh) | 一种治疗咳嗽的中药制剂及其制备方法 | |
| CN100453073C (zh) | 复方半边莲滴丸及其制备方法 | |
| CN105535429A (zh) | 一种治疗帕金森病的中药及其制备方法 | |
| CN102302569B (zh) | 一种具有促进排铅作用的中药组合物 | |
| CN107325071A (zh) | 一种具有降血糖作用的山核桃叶球松素的制备方法和用途 | |
| CN107753551B (zh) | 一种具有降血压功能的组合物及其制备方法 | |
| CN107669727B (zh) | 一种增强舒胸滴丸冠状血管扩张作用的舒胸脉冲控释滴丸及其制备方法 | |
| RU2143272C1 (ru) | Гомеопатическое лекарственное средство для лечения бронхиальной астмы "самбукус-плюс мультигран" | |
| CN102327386B (zh) | 一种促进排铅的中药组合物及其制备方法 |